Biocon gains as its arm, Viatris receive European Commission approval for Kixelle

12 Feb 2021 Evaluate

Biocon is currently trading at Rs. 409.10, up by 2.35 points or 0.58% from its previous closing of Rs. 406.75 on the BSE.

The scrip opened at Rs. 408.00 and has touched a high and low of Rs. 411.30 and Rs. 405.45 respectively. So far 62596 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 487.70 on 23-Dec-2020 and a 52 week low of Rs. 235.80 on 19-Mar-2020.

Last one week high and low of the scrip stood at Rs. 413.00 and Rs. 399.85 respectively. The current market cap of the company is Rs. 48996.00 crore.

The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 23.68% and 15.65% respectively.

Biocon’s subsidiary -- Biocon Biologics (BBL) and Viatris have received marketing authorization approval from the European Commission for Kixelle, Biosimilar Insulin Aspart, following the positive recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency.

Kixelle, a fast-acting insulin analog indicated for the treatment of diabetes mellitus in adults, adolescents and children aged 1 year and above, has been approved as a 100 units/ml solution for injection in vial and pre-filled pen presentations. The centralized marketing authorization granted by the EC is valid in all EU Member States as well as in the European Economic Area (EEA) countries Iceland, Liechtenstein and Norway.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×